Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment.
Pettit AC, Mendes A, Jenkins C, Napravnik S, Freeman A, Shepherd BE, Dowdy D, Gill J, Rachlis A, Moore R, Sterling TR; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) investigators of International epidemiologic Databases to Evaluate AIDS (IeDEA). Pettit AC, et al. Among authors: gill j. J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):572-8. doi: 10.1097/QAI.0000000000001018. J Acquir Immune Defic Syndr. 2016. PMID: 27049511 Free PMC article.
Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment Program.
Montaner JS, Rachlis A, Beaulieu R, Gill J, Schlech W, Phillips P, Auclair C, Boulerice F, Schindzielorz A, Smaldone L, et al. Montaner JS, et al. Among authors: gill j. J Acquir Immune Defic Syndr (1988). 1994 Sep;7(9):924-30. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7519674
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.
Montaner JS, Schechter MT, Rachlis A, Gill J, Beaulieu R, Tsoukas C, Raboud J, Cameron B, Salomon H, Dunkle L, Smaldone L, Wainberg MA. Montaner JS, et al. Among authors: gill j. Ann Intern Med. 1995 Oct 15;123(8):561-71. doi: 10.7326/0003-4819-123-8-199510150-00001. Ann Intern Med. 1995. PMID: 7677296 Clinical Trial.
Effect of early versus deferred antiretroviral therapy for HIV on survival.
Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD; NA-ACCORD Investigators. Kitahata MM, et al. Among authors: gill mj. N Engl J Med. 2009 Apr 30;360(18):1815-26. doi: 10.1056/NEJMoa0807252. Epub 2009 Apr 1. N Engl J Med. 2009. PMID: 19339714 Free PMC article.
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study.
Klein MB, Saeed S, Yang H, Cohen J, Conway B, Cooper C, Côté P, Cox J, Gill J, Haase D, Haider S, Montaner J, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall M, Walmsley S. Klein MB, et al. Among authors: gill j. Int J Epidemiol. 2010 Oct;39(5):1162-9. doi: 10.1093/ije/dyp297. Epub 2009 Sep 28. Int J Epidemiol. 2010. PMID: 19786463 No abstract available.
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
Klein MB, Rollet KC, Saeed S, Cox J, Potter M, Cohen J, Conway B, Cooper C, Côté P, Gill J, Haase D, Haider S, Hull M, Moodie E, Montaner J, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall M, Walmsley S; Canadian HIV-HCV Cohort Investigators. Klein MB, et al. Among authors: gill j. HIV Med. 2013 Jan;14(1):10-20. doi: 10.1111/j.1468-1293.2012.01028.x. Epub 2012 May 28. HIV Med. 2013. PMID: 22639840 Free article.
Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis.
Antiretroviral Therapy Cohort Collaboration (ART-CC); Shepherd BE, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR. Antiretroviral Therapy Cohort Collaboration (ART-CC), et al. Among authors: gill j. AIDS. 2013 May 15;27(8):1321-9. doi: 10.1097/QAD.0b013e32835faa95. AIDS. 2013. PMID: 23925379 Free PMC article.
3,252 results